Cilnidipine, an N+L-type dihydropyridine Ca channel blocker, suppresses the occurence of ischemia/reperfusion arrhythmia in a rabbit model of myocardial infarction

Hypertension Research

Volumn 28, Issue 4, 2005, Pages 361-368

  Nagai, Hiroshi ^a   Minatoguchi, Shinya ^a   Chen, Xue Hai ^a   Wang, Ningyuan ^a   Arai, Masazumi ^a   Uno, Yoshihiro ^a   Lu, Chuanjiang ^a   Misao, Yu ^a   Onogi, Hirohito ^a   Kobayashi, Hiroyuki ^a   Takemura, Genzou ^a   Maruyama, Rumi ^a   Fujiwara, Takako ^b   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

Cilnidipine; Infarct size; Noradrenaline; Reperfusion arrhythmia

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CILNIDIPINE; NORADRENALIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART INNERVATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; MALE; NONHUMAN; RABBIT; REPERFUSION INJURY; SYMPATHETIC NERVE;

ANIMALS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, N-TYPE; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; HEART RATE; INCIDENCE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NOREPINEPHRINE; RABBITS; SURVIVAL RATE; SYMPATHETIC NERVOUS SYSTEM; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION; VENTRICULAR PREMATURE COMPLEXES;

EID: 21244473657     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.28.361     Document Type: Article

References (32)

1. Maseri A, Chierchia S: Coronary spasm: demonstration, definition, diagnosis, and consequences. Prog Cardiovasc Dis 1982; 25: 169-192.
2. Opie LH: Should calcium antagonist be used after myocardial infarction? Ischemia selectivity versus vascular selectivity. Cardiovasc Drugs Ther 1993; 6: 19-24.
3. 2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurons. Br J Pharmacol 1997; 122: 37-42.
4. Hosono M, Fujii S, Hiruma T, et al: Inhibitory effect of cilnidipine on vascular sympathetic neurotransmission and subsequent vasoconstriction in spontaneously hyperttensive rats. Jpn J Pharmacol 1995; 69: 127-134.
5. Daitoku K, Seya K, Motomura S: Cilnidipine suppresses DMPP-induced cardiac sympathetic nerve activation in canine blood-perfused papillary muscle. J Cardiovasc Pharmacol 1999; 34 (Suppl 4): S81-S84.
6. Minami J, Ishimitsu T, Higashi T, Numabe A, Matsuoka H: Comparison between cilnidipine and nisoldipine with respect to effects on blood pressure and heart rate in hypertension. Hypertens Res 1998; 21: 215-219.
7. Yagi S, Goto S, Yamamoto T, Kurihara S, Katayama S: Effect of cilnidipine on insulin sensitivity in patients with essential hypertension. Hypertens Res 2003; 26: 383-387.
8. Takami T, Shigemasa M: Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res 2003; 26: 609-614.
9. Akiyama T, Yamazaki T, Ninomiya I: Differential regional responses of myocardial interstitial noradrenaline levels to coronary occlusion. Cardiovasc Res 1993; 27: 817-822.
10. O Minatoguchi S, Uno Y, Kariya T, et al: Crosstalk among noradrenaline, adenosine and protein kinase C in the mechanisms of ischemic preconditioning. J Cradiovasc Pharmacol 2003; 41 (Suppl 1): S39-S47.
11. Penny WJ: The deleterious effects of myocardial catecholamines on cellular electrophysiology and arrythmias during ischaemia and reperfusion. Eur Heart J 1984; 5: 960-973.
12. Zhan CY, Tang F, Lee AY, Wong TM: Effects of reserpine treatment on arrythmogenesis during ischaemia and reperfusion in the isolated rat heart. Clin Exp Pharmacol Physiol 1989; 16: 591-596.
13. van Gilst WH, de Graeff PA, Kingma JH, de Langen CD, Wesseling H: Effects of diltiazem on reperfusion-induced arrythmias in vitro and in vivo. J Mol Cell Cardiol 1986; 18: 1255-1266.
14. Horwitz LD, Fennessey PV, Shikes RH, Kong Y: Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion. Circulation 1994; 89: 1792-1801.
15. Reimer KA, Vander Heide RS, Richard VJ: Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol 1993; 72: 13G-21G.
16. Norris RM: Beta blockers and infarct size. J Mol Cell Cardiol 1986; 19 (Suppl 4): 99-103.
17. Toyooka T, Kamishiro T, Fumino H, Masaki T, Hosoda S: Rabbit hearts for the critical evaluation of drugs to reduce the size of experimentally produced acute myocardial infarction. Jpn Heart J 1984; 25: 623-632.
18. Tomiyama H, Kimura Y, Kuwabara Y, et al: Cilnidipine more highly attenuates cold pressor stress-induced platelet activation in hypertension than does amlodipine. Hypertens Res 2001; 24: 679-684.
19. 2+ channel blocker cilnidipine on neuronally mediated chronotropic response in anesthetized dogs. Eur J Pharmacol 2001; 413: 117-120.
20. Sakata K, Shirotani M, Yoshida H, et al: Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension. Hypertension 1999; 33: 1447-1452.
21. Lombardi F, Verrier RL Low B: Relationship between sympathetic neural activity, coronary dynamics, and vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion. Am Heart J 1983; 105: 958-965.
22. Naito H, Furukawa Y, Chino D, Yamada C, Hashimoto K: Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrythmias. Eur J Pharmacol 2000; 388: 171-176.
23. Cinca J, Worner F, Carreno A, Bardaji A, Salas-Caudevilla A, Soler-Soler J: Reperfusion arrythmias after chronic regional denervation of the ischaemic myocardium in pigs. Cardiovasc Res 1992; 26: 962-967.
24. 2+-antagonism. Clin Exp Pharmacol Physiol 1991; 18: 217-221.
25. Yamaguchi N, Kimura T, Lamontagne D, de Champlai J, Nadeau R: Occlusion time dependency of regional noradrenaline release and cardiac arrythmias during reperfusion of acutely ischaemic heart in the dog in vivo. Cardiovasc Res 1990; 24: 688-696.
26. Thandroyen FT, McCarthy J, Burton KP, Opie LH: Ryanodine and caffeine prevent ventricular arrythmias during acute myocardial ischemia and reperfusion in rat heart. Circ Res 1988; 62: 306-314.
27. Kihara Y, Morgan JP: Intracellular calcium and ventricular fibrillation: studies in the aequorin-loaded isovolumic ferrer heart. Circ Res 1991; 68: 1378-1389.
28. Brooks WW, Conrad CH, Morgan JP: Reperfusion induced arrythmias following ischaemia in intact rat heart: role of intracellular calcium. Cardiovasc Res 1995; 29: 536-542.
29. Hirayama Y, Saitoh H, Atarashi H, Hayakawa H: Electrical and mechanical alternans in canine myocardium in vivo: dependence on intracellular calcium cycling. Circulation 1993; 88: 2894-2902.
30. Woodward B, Zakaria MNM: Effect of some free radical scavengers on reperfusion induced arrhythmia in the isolated rat heart. J Mol Cell Cardiol 1985; 17: 485-493.
31. Bernier M, Hearse DJ, Manning AS: Repefusion-induced arrhythmia and oxygen-derived free radicals: studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res 1986; 58: 331-340.
32. i and tension in fetal and adult cerebral arteries. Am J Physiol 1999; 277: R286-R294.